TimeMon-Sat 9.00 AM - 6.00 PM
Tenofovir Disoproxil Fumarate & Emtricitabine Tablets

Tenofovir Disoproxil Fumarate & Emtricitabine Tablets

900.0 INR/Pack

Product Details:

  • Drug Type Specific Drug
  • Ingredients TENOFOVIR DISOPROXIL FUMARATE & EMTRICITABINE TABLETS
  • Physical Form Tablets
  • Recommended For AS PER INSTRUCTIONS
  • Dosage AS PER INSTRUCTIONS
  • Dosage Guidelines As per instruction
  • Storage Instructions AS PER INSTRUCTION
  • Click to view more
X

Tenofovir Disoproxil Fumarate & Emtricitabine Tablets Price And Quantity

  • 900.0 INR/Pack
  • 100 Pack

Tenofovir Disoproxil Fumarate & Emtricitabine Tablets Product Specifications

  • AS PER INSTRUCTIONS
  • AS PER INSTRUCTIONS
  • AS PER INSTRUCTION
  • As per instruction
  • Tablets
  • Specific Drug
  • TENOFOVIR DISOPROXIL FUMARATE & EMTRICITABINE TABLETS

Tenofovir Disoproxil Fumarate & Emtricitabine Tablets Trade Information

  • Ahmedabad and Mumbai
  • Telegraphic Transfer (T/T)
  • 1000 Pack Per Month
  • 2 Week
  • 1X30 TABLETS BOTTLE
  • AS PER AVAILABILITIES

Product Description

GENERIC NAME:TENOFOVIR DISOPROXIL FUMARATE & EMTRICITABINE TABLETS

PACKING: 1X30 TABLETS BOTTLE

USES: This product is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of two different drugs: emtricitabine and tenofovir. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir is called a nucleotide reverse transcriptase inhibitor. They are often called NRTIs.




Key Ingredients and Composition

This product contains Tenofovir Disoproxil Fumarate and Emtricitabine in tablet form, two well-established agents for controlling HIV replication. Their synergistic effect helps reduce viral load and improves immune function when taken according to medical advice.


Proper Dosage and Administration

Dosage should always be tailored to individual needs as per healthcare providers instructions. It is essential to follow prescribed guidelines exactly to maximize the therapeutic benefit and minimize potential side effects.


Storage and Handling Recommendations

Ensure these tablets are stored as directed, typically in a cool, dry location away from direct sunlight and moisture. Proper storage safeguards the medicines potency and prevents accidental damage.

FAQs of TENOFOVIR DISOPROXIL FUMARATE & EMTRICITABINE TABLETS:


Q: How should I take TENOFOVIR DISOPROXIL FUMARATE & EMTRICITABINE TABLETS?

A: You should take these tablets exactly as instructed by your healthcare provider, typically once daily with or without food. Abiding by prescribed dosage timing ensures maximum effectiveness.

Q: What are the benefits of using this combination medicine?

A: TENOFOVIR DISOPROXIL FUMARATE & EMTRICITABINE TABLETS help control HIV infection by reducing viral load and supporting immune strength, potentially lowering the risk of developing AIDS-related complications.

Q: When is the best time to take these tablets?

A: It is generally recommended to take your dose at the same time each day to maintain consistent drug levels in your body. Always follow your doctors timing advice for optimal results.

Q: Where should I store these tablets for best preservation?

A: Store the tablets according to instructions provided, usually in a cool, dry place away from direct sunlight and moisture to maintain their effectiveness and prevent spoilage.

Q: What is the process for starting this medication?

A: Consult your healthcare provider for an initial assessment, prescription, and guidance on correct usage. An individualized dosage plan will be created to match your specific medical needs.

Q: Can these tablets be used as a preventive measure against HIV?

A: Yes, under medical supervision, TENOFOVIR DISOPROXIL FUMARATE & EMTRICITABINE TABLETS may be prescribed for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection in high-risk individuals.

Q: Who should not use this medication?

A: Individuals with allergies to any ingredient or specific health conditions should inform their healthcare provider before starting therapy, as suitability and safety must be assessed case by case.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'HIV AND Hepatitis Medicine' category



Back to top